Clinical Trial Update: Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Edaravone Injection in the treatment of acute ischemic stroke, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Edaravone Injection (edaravone)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 3 | Status: COMPLETED